Tinninus Assessment Technology

MENODYS announces the publication of new trial results led by Pr. Sylvie Hébert in JAMA Otolaryngology – Head & Neck Surgery on comparing its Patient-centered Tinnitus Likeness Rating Technology to the Standard Clinical Method for the Assessment of Tinnitus Pitch and Loudness Matching

Longueuil, Quebec, Canada – Pr. Sylvie Hébert of the School of Speech Pathology and Audiology of the Université de Montréal has published in JAMA Otolaryngology – Head & Neck Surgery the results of a new study from a research project comparing the patient centered Tinnitus Likeness Rating technology developed by MENODYS to the standard clinical forced-choice method used for the assessment of tinnitus Pitch and Loudness Matching used by audiology clinicians around the world.

31 patients with established diagnosis of tinnitus for at least 6 months were evaluated twice, each time with a different audiologist, , using 2 different methods of assessment of the tinnitus pitch and loudness matching. Visits were separated by 30 days.

The research project’s main objective was to define if a new patient-centered Tinnitus Likeness Rating (TLR) approach can provide a greater test-retest 1-month reproducibility than the Standard Clinical forced-choice Method for tinnitus assessment.

For the TLR, 26 of 31 participants had a least 1 concordant dominant frequency between the two visits versus only 7 of 31 participants with the Standard Clinical forced-choice Method. Loudness reliability followed the same pattern.

In conclusion, superior test-retest concordance can be demonstrated at individual level using several dominant frequencies extracted from the patient-centered TLR technology of MENODYS and as such is a significant improvement for the study of personalized therapeutic interventions in Tinnitus.

“This study and its publication is an important milestone for MENODYS in confirming the value of its Patient-centered Tinnitus Likeness Rating Technology as a new mean for audiology clinicians around the world to have access to a reliable test-retest technology for tinnitus assessment and evaluation of tinnitus symptom attenuation protocol benefits over time”, said Richard Côté, Executive Vice President of MENODYS.

Tinnitus is an important and growing worldwide health issue in audiology affecting more than 360,000 Canadians, 30 million Americans and over 120 million Europeans.

MENODYS is a Canadian company specialized in the development and commercialization of medical technologies. www.menodys.com